Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Eyebright Medical Technology (Beijing) Co., Ltd.
  6. News
  7. Summary
    688050   CNE1000041J5

EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

(688050)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Certain A Shares of Eyebright Medical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-JUL-2021.

07/29/2021 EDT

Certain A Shares of Eyebright Medical Technology (Beijing) Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-JUL-2021. These A Shares will be under lockup for 372 days starting from 22-JUL-2020 to 29-JUL-2021. Details: The company's controlling shareholders and the actual controllers Xie Jiangbing, Mao Liping, Bai Ying, Beijing Bojian Hechuang Technology Co., Ltd., Ningbo Meishan Bonded Port Bojian Chuangzhi Investment Partnership Enterprise (L.P.) and Ningbo Meishan Bonded Port Xitianyou Investment Partnership Enterprise (L.P.), the Shareholder and People acting in concert of the actual controller committed not to transfer or entrust to a third party the company’s shares it holds directly or indirectly before the public offering, or allow the company to repurchase these shares within 36 months since the company’s share listing date. Other shareholders Fuda Chengzhang (Shanghai) Equity Investment Partnership (Limited Partnership), Beijing Longpan Biomedical Venture Capital Center (Limited Partnership), Century Sunshine Group Holdings Limited, Shanghai Nuoyi Investment Management Co., Ltd., Beijing Qidi Rixin Venture Capital Co., Ltd., Hangzhou Junfeng Equity Investment Partnership (Limited Partnership), Huaqing Bencao Nantong Equity Investment Center (Limited Partnership), Yingfutaiike National Emerging Industry Venture Capital Guiding Fund (Limited Partnership), Beijing Changkejin Investment Co., Ltd., Wuhan Bohang Wendaso Venture Capital Partnership (Limited Partnership), Ningbo Meishan Bonded Port Xitianyou Investment Partnership Enterprise (L.P.), Liu Fu’an, Beijing Shunqi Health Equity Investment Fund Management Center (Limited Partnership), Wuhan Bohang Wendao Investment Management Center (Limited Partnership), Yu Zhihua, Shen Yousheng, Shanghai Guoyao Equipment Equity Investment Fund Partnership (Limited Partnership), Wei Xiaoyue, Luo Zhangsheng, Beijing Qidi Yinxing Angel Investment Center (Limited Partnership), Luo Zhuo, Hangzhou Xianfeng Qiyun Investment Partnership (Limited Partnership), Xu Shuiyou and Shanghai Shengqi Investment Management Partnership (Limited Partnership) committed not to transfer or entrust to a third party the company’s shares it holds directly or indirectly before the public offering, or allow the company to repurchase these shares within 36 months since the company’s share listing date.


© S&P Capital IQ 2021
All news about EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
08/11Eyebright Medical Technology Beijing Co., Ltd. Reports Earnings Results for the Half Ye..
CI
07/30EYEBRIGHT MEDICAL TECHNOLOGY CO., LT : 688050) added to Shanghai Stock Exchange A Share In..
CI
07/29EYEBRIGHT MEDICAL TECHNOLOGY CO., LT : 688050) added to Shanghai Stock Exchange Composite ..
CI
07/29Certain A Shares of Eyebright Medical Technology Co., Ltd. are subject to a Lock-Up Agr..
CI
04/19Eyebright Medical Technology Beijing Co., Ltd. Reports Earnings Results for the First Q..
CI
03/31Eyebright Medical Technology Co., Ltd. entered into a framework agreement to acquire a ..
CI
03/30Eyebright Medical Technology Beijing Co., Ltd. Reports Earnings Results for the Full Ye..
CI
03/30Jiangsu Tianyan Pharmaceutical Technology Co., Ltd. announced that it expects to receiv..
CI
2020Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the First Three Qua..
CI
2020Eyebright Medical Technology Co., Ltd. Reports Earnings for the First Half of 2020
CI
More news
Financials
Sales 2021 405 M 63,5 M 63,5 M
Net income 2021 153 M 23,9 M 23,9 M
Net Debt 2021 - - -
P/E ratio 2021 183x
Yield 2021 0,11%
Capitalization 27 965 M 4 381 M 4 381 M
Capi. / Sales 2021 69,0x
Capi. / Sales 2022 49,1x
Nbr of Employees 503
Free-Float 46,4%
Chart EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
Duration : Period :
Eyebright Medical Technology (Beijing) Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 265,98 CNY
Average target price 322,55 CNY
Spread / Average Target 21,3%
EPS Revisions
Managers and Directors
Jiang Bing Xie Chairman, General Manager & Chief Scientist
Yan Chang Guo Chief Financial Officer & Director
Dan Xuan Wang Chairman-Supervisory Board
Zhao Wang Senior Director-Technical
Yu Jiao Wang Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.53.76%4 349
STRAUMANN HOLDING AG76.15%31 294
SONOVA HOLDING AG57.22%24 734
DEMANT A/S21.11%10 877
COCHLEAR LIMITED16.03%10 492
ÖSSUR HF.-8.15%2 930